When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AUPH - Aurinia's voclosporin successful in late-stage lupus nephritis study
Aurinia Pharmaceuticals Inc
A 357-subject Phase 3 clinical trial evaluating Aurinia Pharmaceuticals' (NASDAQ:AUPH) lead drug voclosporin, combined with mycophenolate and low-dose corticosteroids, in lupus nephritis patients met the primary and key secondary endpoints.
More news on: Aurinia Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move,